US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

CNS/Neurology Market Research Reports & Industry Analysis

RSS Feeds

CNS/Neurology Industry Research & Market Reports

1  2    4    6  7  8  9  10  
Astrocytoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Astrocytoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Astrocytoma- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Ataxia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Ataxia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Ataxia- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Brain Cancer-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Cancer Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Cancer- Pipeline ...  |  read more...
USD 1,250
Brain Hemorrhage-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Hemorrhage Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Hemorrhage- Pipeline ...  |  read more...
USD 1,250
Brain Ischemia-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Ischemia Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Ischemia- Pipeline ...  |  read more...
USD 1,250
Brain Metastasis-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Brain Metastasis Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Brain Metastasis- Pipeline ...  |  read more...
USD 1,250
Cognitive Impairment Associated With Schizophrenia (CIAS)-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... (CIAS). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Cognitive Impairment Associated With Schizophrenia (CIAS) Report helps to identify emerging players with ...  |  read more...
USD 1,250
Delirium-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Delirium Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Delirium- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Diabetic Neuropathy-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Diabetic Neuropathy Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Diabetic Neuropathy- Pipeline ...  |  read more...
USD 1,250
Down Syndrome-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Down Syndrome Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Down Syndrome- Pipeline ...  |  read more...
USD 1,250
Drug Addiction-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Drug Addiction Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Drug Addiction- Pipeline ...  |  read more...
USD 1,250
Mania-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Mania Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Mania- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Metastatic Brain Tumor-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Metastatic Brain Tumor Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. ...  |  read more...
USD 1,250
Neuroblastoma-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Neuroblastoma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Neuroblastoma- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Obsessive-Compulsive Disorder-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Obsessive-Compulsive Disorder Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Obsessive-Compulsive Disorder- Pipeline ...  |  read more...
USD 1,250
Partial Seizure-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... related research activities, technology, collaborations, in-licensing and out-licensing deals. The Partial Seizure Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Partial Seizure- Pipeline ...  |  read more...
USD 1,250
Recurrent Malignant Glioma -Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The Recurrent Malignant Glioma Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to ...  |  read more...
USD 1,250
Seizures-Pipeline Insights, 2015
5/18/2015 | published by: DelveInsight
... technology, collaborations, in-licensing and out-licensing deals. The Seizures Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage. DelveInsight’s, Seizures- Pipeline Insights, 2015 Report covers the ...  |  read more...
USD 1,250
Global Depression Therapy & Treatment Market – Depression drugs and devices, SSRIs, Fischer wallace stimulator, Transcranial magnetic stimulation, Electroconvulsive Pipeline Analysis, Global Analysis, Share, Growth, Trends, Forecast 2014 – 2020
5/17/2015 | published by: Occams Business Research & Consultancy
... of emotion that affects thoughts, actions and often, sleeping patterns of affected individual. Depression affects behavior in terms of loss of appetite, being in a constant state of despair, feeling disconnected with friends/family and disinterest ...  |  read more...
USD 4,000
Europe Neuromodulation Devices Market by Procedure [Internal Stimulation (DBS, GES, SNS, SCS, VNS), and External Stimulation (TENS, TMS)], and by Geography – Analysis & Forecast to 2019
5/18/2015 | published by: MicroMarketMonitor
... Increasing incidences of peripheral nerve injuries and neurological disorders, technological developments in nerve repair, and favorable reimbursement policies are expected to drive the market growth in this region. However, lacks of surgeons and patient awareness ...  |  read more...
USD 2,650
Blood Brain Barrier Technologies: Novel CNS Drug Delivery Approaches’
5/12/2015 | published by: Roots Analysis
... not treat the root cause. This is because of their inability to penetrate across the blood brain barrier (BBB). BBB is a highly selective permeable membrane which allows the entry of only specific molecules, across ...  |  read more...
USD 2,199
Substance (Drug) Abuse - Pipeline Review, H1 2015
4/30/2015 | published by: Global Markets Direct
... information on the therapeutic development for Substance (Drug) Abuse, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
Treatment Resistant Depression - Pipeline Review, H1 2015
4/29/2015 | published by: Global Markets Direct
... information on the therapeutic development for Treatment Resistant Depression, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
The 2016-2021 World Outlook for Neurodegenerative Drugs
4/6/2015 | published by: Icon Group International, Inc.
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly ...  |  read more...
USD 995
Physician Views: Anti-CGRP mAbs looking to shake up migraine prevention – how and where will they fit in?
5/1/2015 | published by: FirstWord
... exceedingly difficult to target with pharmaceuticals. As it turns out, the key was moving on from small molecules, where companies like Boehringer Ingelheim and Merck & Co. ran into problems with off-target liver toxicities, and ...  |  read more...
USD 695
1  2    4    6  7  8  9  10